Collectively these data suggest that rRAS activation offers protection against many of the pathological disease processes associated with cRAS activation that are characteristic in AD but may in addition directly benefit normal cognition, through promoting synaptic plasticity processes linked to memory. This evidence concerns the gene RRAS and Alzheimer disease.